CAGE Bio begins double-blind placebo-controlled clinical trial of topical DNA Aptamer therapy CGB-600 for vitiligo treatment: San Carlos, California Saturday, October 25, 2025, 12 ...
Incyte INCY has put up a stellar performance year to date on the back of better-than-expected quarterly results, and positive ...
Incyte's growth potential and low valuation are driven by a strong pipeline and strategic focus. Read here for an investment analysis of INCY stock.
The FDA rounded out the month with the approval of remibrutinib (Rhapside; Novartis), a highly selective Bruton tyrosine kinase inhibitor (BTKi), for patients with chronic spontaneous urticaria (CSU) ...
Encompass Health Corp. today announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.19 per share, payable on Jan. 15, 2026, to holders of record on Jan.
The Miss USA 2025 pageant will be held in Reno on Friday. This year's contestants include an "American Ninja Warrior" ...
Macrobond, the leading provider of global economic and financial data and analytics, today announced a strategic integration with FactSet, a global digital platform and enterprise solutions provider.
Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: 4 Clinical-Stage Biotechs to Watch as the Sector Rebounds (MDCX, AUPH, LEXX, EDSA) ...
From how much sleep you are getting to whether you are eating the right diet, scientists say that hair holds the secrets to ...
Mona Shahriari, MD, assistant clinical professor of dermatology at Yale University and associate director of clinical trials at Central Connecticut Dermatology, discusses how dermatologists and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback